Post-operative aspergillosis  by Pasqualotto, A.C. & Denning, D.W.
REVIEW 10.1111/j.1469-0691.2006.01512.x
Post-operative aspergillosis
A. C. Pasqualotto and D. W. Denning
School of Medicine, The University of Manchester and Wythenshawe Hospital, Manchester, UK
ABSTRACT
While invasive aspergillosis occurs typically in severely immunocompromised patients, cases of surgical
site infection have been reported in immunocompetent individuals. The Medline, LILACS and EMBASE
databases were searched for descriptions of cases of post-operative aspergillosis, and references from
relevant articles and conference abstracts were reviewed. More than 500 cases of post-operative
aspergillosis were found. Cardiac surgery (n = 188), ophthalmological surgery (n > 90) and dental
surgery (n > 100) were associated with the majority of cases. Other cases involved wound infections
(n = 22), bronchial infections (n = 30), mediastinitis (n = 11), pleural aspergillosis (n = 1), infections
following orthopaedic surgery (n = 42), vascular prosthetic surgery (n = 22), breast surgery (n = 5),
abdominal surgery (n = 10) and neurosurgery (n = 25). In most patients, the source was presumed to be
airborne infection during the surgical procedure. Prevention of these infections requires special care of
the ventilation system in the operating room. Successful treatment requires rapid diagnosis, surgical
debridement and antifungal therapy, often with voriconazole. In order to improve the outcome, better
diagnostic methods are needed, particularly for cases of endocarditis and aortitis.
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INTRODUCTION
Fungi belonging to the genus Aspergillus are
ubiquitous and occur in soil, water and decaying
vegetation [1,2]. Like other ﬁlamentous fungi,
Aspergillus is acquired primarily from an inanim-
ate reservoir, usually by the inhalation of small
airborne spores [3]. While nosocomial aspergil-
losis typically affects immunocompromised pa-
tients [4], post-operative aspergillosis occurs
mainly in immunocompetent patients, including
some patients who received corticosteroids tem-
porarily. This review is based on a search of the
world literature to identify cases of post-operative
aspergillosis occurring after surgical procedures
that were not secondary to disseminated infection
or previous known colonisation by Aspergillus
spp.
PATIENTS AND METHODS
Search strategy
The Medline, LILACS and EMBASE databases were searched
and references from relevant articles were reviewed. Search
terms were ‘aspergillus’, ‘surgery’, ‘surgical site infections’,
‘cardiovascular surgical procedures’, ‘endocarditis’, ‘aortitis’,
‘mediastinitis’, ‘breast’, ‘laparotomy’, ‘arthroplasty’, ‘orthopae-
dic procedures’, ‘neurosurgery’, ‘transplantation’, ‘ophthal-
mologic surgical procedures’, ‘osteomyelitis’, ‘prosthesis’,
‘treatment’ and ‘prevention’. Conference abstracts were re-
viewedusing theAspergillusweb-site (http://www.aspergillus.
man.ac.uk). Apart from papers published in Japanese,
Russian, Czech or Polish, no language restrictionswere applied.
Non-surgical cases of primary cutaneous aspergillosis and
infections associated with intravascular devices were not con-
sidered for this review.
Deﬁnitions
Only cases of proven or probable infection were reviewed,
which required that all cases included were laboratory-
conﬁrmed by culture and ⁄or histology and ⁄ or microscopy.
These criteria were based on standard deﬁnitions for invasive
fungal infections in immunocompromised patients for clinical
research [5]. As the incubation period of aspergillosis is not
well-established, this review was not limited by the CDC
deﬁnitions of surgical site infection (i.e., infections occurring
within 30 days of a surgical procedure if no implant is left in
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place, or within 1 year if an implant is present) [6]. Wound
aspergillosis was deﬁned as infections involving only the skin
or subcutaneous tissue of the incision. Infections that involved
both superﬁcial and deep incision sites were classiﬁed as deep
surgical site infections, according to the site affected. For
classiﬁcation as a wound infection, in addition to a positive
culture of Aspergillus spp. taken directly from the wound, the
wound itself had to be non-healing following treatment with
standard antibiotics, with other pathogens absent or minimally
present.
LITERATURE REVIEW
From the initial search, c. 450 papers were exclud-
ed for several reasons, including cases of asper-
gillosis unrelated to surgery and disseminated
infections from pulmonary or other sources.
Other review articles with no new contributions
were also excluded. More than 500 patients with
post-operative aspergillosis were included in this
review, including cases following heart surgery
(188), neurosurgery (25), dental surgery (>100),
ophthalmological surgery (>90), orthopaedic sur-
gery (42), vascular prosthetic surgery (22),
abdominal surgery (10) and breast surgery (5).
Reports of wound infections (22), bronchial infec-
tions (30), mediastinitis (11) and pleural aspergil-
losis (1) were also included. Some cases were
reported more than once, i.e., [10] and [11]; [16]
and [129]. Table 1 summarises the key aspects of
Table 1. Summary of main clinical
presentations, treatment and pro-
phylaxis of cases of post-operative
aspergillosis
Comments
Clinical presentation
Endocarditis ⁄ aortitis (n = 174) Marked male predominance (c. 70%)
Absence of immunosuppression for almost all patients
Aortic valve mostly involved (60.5%)
Median time from surgery to diagnosis = 2.7 months
Aspergillus fumigatus: aetiology in only 58.7% of cases
Low ante-mortem diagnosis (43.5%), usually following surgical
intervention
Blood cultures rarely positive (6.4%)
Propensity for late embolisation
Mortality >80% despite intervention (overall mortality 92.7%)
Neurosurgery infections (n = 25) Frequently associated with the use of steroids (52.0%)
All proven cases caused by A. fumigatus
Median time from surgery to diagnosis = 3 months
Higher ante-mortem diagnosis rate (68.0%) than for endocarditis
Mortality much lower than observed for immunocompromised
patients with aspergillosis disseminated to the central nervous
system
Dental surgery infections (n > 100) Many cases of sinus aspergillosis associated with endodontic
treatment
Obturating pastes within the maxillary antrum probably a risk-
factor
Wound infections (n = 22) Most patients immunosuppressed
Median time from surgery to diagnosis = 17 days
A. ﬂavus accounts for 41.2% of cases conﬁrmed by culture
Risk of dissemination
Ophthalmological surgery infections (n > 90) Usually presents as keratitis
Diagnosis requires sampling at the site of infection
Vascular prosthesis infections (n = 22) Almost all patients are male and immunocompetent
Median time from surgery to diagnosis = 8 months
Clinical picture indistinguishable from Staphylococcus epidermidis
infections
Usually occurs close to suture lines of previous aortotomy
High incidence of embolisation to vertebral disks
Other cases (n = 113) Frequent association with prosthesis insertion
Treatment The optimal treatment has not been speciﬁcally studied
Survival seemingly dependent on excision of the infected tissue; in
cases involving a prosthesis, the new prosthesis should be placed
in a non-infected ﬁeld
Concomitant use of a systemic antifungal agent is also crucial.
Although there are no data favouring any one antifungal drug, the
response rates to voriconazole in immunocompromised patients
were superior to those in response to amphotericin B. Caspofungin
and other echinocandins may also be useful. Longer-term oral
extension with itraconazole or voriconazole is appropriate for
some patients
The optimal duration of therapy is unknown and is likely to differ
between patients, but once as much infected tissue as possible has
been removed and any immunocompromising factors, such as
corticosteroid therapy, are minimised, treatment for 3 months
beyond the last evidence of active disease may be appropriate
Prevention Requires special care with the ventilation system in the operating
theatre
Proper disinfection and storage of surgical materials
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post-operative aspergillosis following different
surgical procedures.
The ﬁrst case reported in the literature
In 1933, a female aged 14 years underwent sur-
gery for an abdominal tumour [7]. After 16 days,
the dressing was removed and an ulcer was
observed. There were no systemic manifestations
of the infection, but Aspergillus niger grew in the
surgical dressings, which were covered with a
‘dark powder’. It was speculated that contamin-
ation may have occurred in the operating room,
and the authors commented on two previous
similar cases of wound aspergillosis in the same
medical centre, each exhibiting similar pustula-
tion conﬁned to the area of the gauze dressing,
and with rapid healing after local treatment with
iodine and alcohol.
Endocarditis, aortitis and other presentations of
aspergillosis following cardiac surgery
Table S1 (see Supplementary material) summa-
rises some clinical details for 124 patients with
Aspergillus endocarditis or aortitis following heart
surgery [4,8–91]. The median age of these patients
was 43.5 (range 0.8–71) years. Most of the surgical
procedures involved the aortic (60.5%) or mitral
(30.6%) valve, and no particular prosthesis was
associated with the infection. Male patients pre-
dominated (69.9%), which may be related to the
higher prevalence of coronary and aortic valve
surgery in males than in females. The incubation
period was variable, with a mean time from
surgery to the diagnosis (often following autopsy)
of 2.7 (range <1 to >12) months. Two cases [43,88]
had possible incubation periods of several years;
silent Aspergillus fungaemia with late endocarditis
is possible in such cases, although there is no
direct evidence for such a diagnosis. Forty addi-
tional cases were cited in other studies, but
without detailed information [92–111], and at
least ten additional cases were reported in lan-
guages other than English [112–120].
Notably, almost none of the patients were
immunosuppressed, and there was no evidence
of bronchopulmonary aspergillosis. The post-
operative course of these patients was usually
consistent with culture-negative endocarditis.
Unusual presentations of aspergillosis following
heart surgery included osteochondritis and ⁄ or
osteomyelitis after sternotomy [78,121–125], and
saphenous vein thrombosis [126] or rupture [127]
after coronary by-pass surgery.
Aspergillus fumigatus was the aetiological
agent in only 58.7% of cases conﬁrmed by
culture. Other important species were Aspergillus
terreus (12.5%), which is resistant to amphoter-
icin B, A. niger (11.2%) and Aspergillus ﬂavus
(11.2%). Most reports associated the infection
with contaminated grafts, contaminated sutures
or intra-operative dispersion of spores. The
prevention of such infections will be considered
below.
The difﬁculty in establishing the diagnosis of
Aspergillus endocarditis is well-known, since the
fungus is isolated infrequently from blood
cultures. Only eight cases of post-operative asper-
gillosis associated with a positive blood cul-
ture (6.4% of cases) were found in the literature
[11,12,14,36,38,46,61,87]. Pre-autopsy diagnosis
was made in only 43.5% of cases. In the vast
majority of cases, surgical intervention was cru-
cial in obtaining a deﬁnitive diagnosis, often
following examination of either the valve
(23.4%) or emboli to large peripheral arteries
(16.9%). Unfortunately, some surgical specimens
were not sent for culture. The diagnosis of
Aspergillus aortitis is also made more difﬁcult
because of the localisation of the infection and the
absence of endocarditis vegetation; this condition
is therefore often undetected by both trans-thor-
acic and trans-oesophageal echocardiography.
Computed tomography scan, magnetic resonance
imaging and angiography might be more helpful
for the diagnosis of such cases.
The overall mortality rate was 92.7%. In addi-
tion, 83.0% of patients who had an ante-mortem
diagnosis died, and a high mortality rate (80.9%)
existed even among patients treated with a
surgical intervention in the affected valve. This
might be related to a delayed diagnosis, which
gives the fungus the opportunity to establish large
vegetations, to cause extensive local necrosis, and
eventually to embolise to large arteries. Many of
the patients who underwent valve replacement
died during surgery or a few days later. These
results indicate an unequivocal need for better
diagnostic methods for this condition. At the
present time, the role of antibody tests and
molecular tests of blood samples has not been
properly investigated. In one report, a false-
negative galactomannan result occurred for a
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patient with non-surgical Aspergillus endocarditis,
despite a positive blood culture for A. fumigatus
[128].
Wound infections
For patients with post-operative wound infection
caused by Aspergillus spp., the interval between
surgery and infection is measured in days, rather
than the months required for endocarditis (Table
S2, see Supplementary material) [5,87,129–143] In
addition, many patients with wound aspergillosis
were immunosuppressed, with half of the cases
occurring in solid-organ transplant recipients. As
this condition can progress to profound or dis-
seminated infection, all patients need to be treated
aggressively with combined medical and surgical
therapy. A. ﬂavus is a particularly important
species in wound aspergillosis, accounting for
41.2% of cases conﬁrmed by culture.
Chronic lung disease was the only independent
risk-factor for A. fumigatus sternal wound infec-
tion after open-heart surgery in a case-control
study [144]. A. fumigatus was grown simulta-
neously from the bronchial washings of one
patient, suggesting that colonised patients may
be at increased risk for these infections. In another
study, a cluster of four cases of surgical and burn
wound aspergillosis was associated with the
outside packages of dressing supplies, which
had become contaminated during hospital con-
struction work [145]. This resulted in patients
with large exposed vulnerable surface areas being
inoculated directly with Aspergillus spores. When
outbreaks of cutaneous aspergillosis occur,
wound dressing and tape should be cultured
[146,147]. Cases of A. ﬂavus sternal wound infec-
tion coinciding with hospital renovation activities
have also been reported [148].
Neurosurgery
Involvement of the central nervous system in
aspergillosis may occur via haematogenous dis-
semination (usually from the lungs), or by direct
extension from nasal or paranasal foci [149]. Table
S3 (see Supplementary material) summarises the
published literature concerning aspergillosis fol-
lowing neurosurgical procedures [150–168]. In
contrast to Aspergillus endocarditis, male patients
were not over-represented in neurosurgical infec-
tions (44.0%). Previous treatment with cortico-
steroids was mentioned in 52.0% of the reports,
including patients receiving regimens of pulse
therapy, high-dose regimens for periods of weeks
to months, and even physiological steroid
replacement therapy. The median time from
surgery to diagnosis was 3 (range <1 to >12)
months. All proven cases were caused by A. fu-
migatus. As shown in Table S3, different presen-
tations of the infection can occur, including
meningitis, central nervous system abscesses,
mycotic aneurysms and cerebral infarction. Many
cases were associated with Aspergillus contamin-
ation from paranasal sinuses, particularly follow-
ing trans-sphenoidal surgery.
An ante-mortem diagnosis was performed in
68% of cases, which was a proportion consider-
ably higher than that for cases of Aspergillus
endocarditis. Most of these cases were diagnosed
after abscess drainage (36%), and 20% of patients
had a cerebrospinal ﬂuid culture positive for
Aspergillus. In some cases, a culture positive for
Aspergillus was considered to be contamination,
which was associated with delayed treatment,
sometimes with a fatal outcome. All patients who
survived received combined aggressive clinical
and surgical therapy. The overall mortality rate
was 68.0%, which is surprisingly low in compar-
ison with mortality rates of >90% for immuno-
suppressed patients with disseminated
aspergillosis involving the central nervous sys-
tem. This may reﬂect an earlier diagnosis, facili-
tated by imaging techniques, in association with
aggressive neurosurgical intervention. Further-
more, dexamethasone therapy could be with-
drawn for many of these patients, unlike the
situation for patients with more permanent
immunosuppression.
Dental surgery
A number of studies have reported a connection
between endodontic treatment and non-invasive
sinus aspergillosis, mainly in the presence of
obturating pastes within the maxillary antrum
[169–183]. Experiments with fungal cultures have
revealed accelerated growth of Aspergillus spp. in
the presence of zinc oxide in the culture medium
[182]. With respect to treatment, it is necessary to
remove surgically the fungal masses in the
sinuses, and especially all zinc-containing radio-
paque material, and to ensure establishment of
adequate sinus drainage and aeration [178,181].
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Systemic antifungal agents are generally not
recommended to complement the surgical proce-
dure unless there are signs of local invasion [181].
Ophthalmological surgery
Ocular aspergillosis usually presents as keratitis,
and rarely as endophthalmitis [92,184–187]. Post-
operative infections have been described follow-
ing penetrating keratoplasty [188–190], radial
keratotomy [191–194], excimer laser photo-
refractive keratectomy [195], laser-assisted in-situ
keratomileusis [196–199], pterygium excision
[200,201], hydroxyapatite orbital implant surgery
[202], cataract surgery [179,184,203–212], scleral
buckling procedures [213,214], sutureless surgery
[215,216] and trabeculectomy [204,217]. Sampling
at the site of infection provides the best chance for
obtaining a positive culture [196,218–220]. While
some cases of Aspergillus endophthalmitis and
keratitis have been associated with hospital con-
struction [209,221], others have been linked to
contaminated irrigating ﬂuids used during sur-
gery [208]. Many cases of Aspergillus keratitis and
scleritis following non-surgical corneal trauma
have also been reported [209,222–248], frequently
in farmers. The efﬁcacy of the antifungal therapy
depends to a great extent on the ability of the
compound used to penetrate the eye [219,249].
Orthopaedic surgery
A male aged 64 years underwent hip replacement
surgery and was admitted after a 9-year interval
because of progressive hip pain [250]. A. niger
grew from aspirated hip ﬂuid, and the patient
was treated with amphotericin B and prosthesis
replacement. Two cases of aspergillosis following
laminectomy were also reported in the same
publication. In another report, A. fumigatus
spondylodiskitis occurred 2.5 months after lum-
bar disk surgery, and the patient was treated with
itraconazole in combination with surgical debri-
dement [251]. Other cases following lumbar sur-
gery have also been reported [252–254].
In a prospective study of 658 consecutive total
hip arthroplasty procedures in which cultures
were taken at surgery, Aspergillus was recovered
in 4.1% of cases, and Aspergillus was also culti-
vated from the air in the operating theatre [255].
In another report, a male aged 22 years developed
Aspergillus osteomyelitis after a closed fracture of
the femur and subsequent surgery [256]. Another
male, aged 16 years, developed infection with
A. ﬂavus following surgery for a fracture of the
femur. The infection was associated with pressure
and necrosis caused by casts [257]. The ﬁrst case
of aspergillosis complicating total knee arthropl-
asty was described in a male aged 80 years who
was receiving chronic corticosteroid therapy
[258]. This patient presented with a popliteal cyst
27 months after surgery, and was cured with a 12-
week course of amphotericin B in combination
with surgical debridement and prosthesis re-
moval. Other similar cases have been described
in the literature [259,260].
Bronchopulmonary surgery
Bronchial stump aspergillosis, i.e., Aspergillus
infection of bronchial granulation tissue sur-
rounding endobronchial sutures after pulmonary
resection, is a rare clinical presentation of Asperg-
illus infection [261–267]. This condition is more
common when silk thread is used as the suture
material rather than stainless steel [268,269], and
should be considered in the differential diagnosis
of haemoptysis, coughing and dyspnoea occur-
ring up to several years after lung surgery,
although asymptomatic presentation is also poss-
ible [262–264,269]. Aspergillus suture granuloma
may simulate recurrent neoplastic disease in
patients undergoing resection for pulmonary
cancer [270]. Although no comparative studies
exist, removal of the silk suture is probably the
key therapeutic intervention for this condition.
An association between the presence of sa-
prophytic fungi in the bronchial anastomosis and
the occurrence of serious airway complications
following lung transplantation has been proposed
[271]. The ischaemic and necrotic airway debris at
the bronchial anastomosis provides a fertile envi-
ronment for Aspergillus proliferation. Several
reports have also described an increased risk of
complications as a consequence of post-transplan-
tation saprophytic Aspergillus disease [272–275].
The source of these infections has not been well-
studied, but may be related to either colonisation
of the diseased or transplanted lungs, or to direct
perioperative acquisition.
Pleural aspergillosis has been reported as an
iatrogenic complication of lung adenocarcinoma
resection [276]. A 14-day course of intravenous
caspofungin failed to sterilise the cavity, and
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the patient was treated with a combination of
intra-pleural and systemic amphotericin B lipid
complex.
Infection of vascular prosthesis
Glotzbach [277] seems to have been the ﬁrst to
describe Aspergillus infection of a vascular pros-
thesis in 1982, and this was followed by the report
of an immunocompetent patient, aged 73 years,
with aortic pseudoaneurysm and contiguous ver-
tebral osteomyelitis, who was treated with graft
resection and amphotericin B [278]; as in the
previous case [277], this patient presented with
back pain c. 2 years after surgery. In a study of 14
cases of fungal graft infections [279], only four
were caused by Aspergillus spp.
Aspergillus graft infections usually occur on the
suture line of a previous aortotomy [280]. Deﬁn-
itive diagnostic procedures for these patients
generally involve culture of the excised aortic
graft or the peripheral embolus, and biopsy of the
contiguously affected vertebral disk space
[277,281–284]. As with endocarditis, almost all
cases have involved immunocompetent males
[277,278,281–290]. The median time from the
placement of the graft to diagnosis is 8 months,
which is a longer period than that for Candida
graft infections (usually <6 weeks) [279]. Fever is
absent in about one-half of the cases. One report
associated in-situ replacements or treatment with-
out excision of the infected graft with recurrence
and death in all cases, whereas all patients who
underwent an extra-anatomical by-pass through a
clean ﬁeld survived [279]. No difference seems to
exist between the clinical presentations of fungal
and bacterial vascular prosthesis infections,
particularly when Staphylococcus epidermidis is
involved [291].
Abdominal surgery
Multiple abdominal visceral infection by A. fumig-
atus occurred in a female aged 37 years after
laparostomy for Crohn’s disease [292]. The patient
was treated successfully with a 4-week course of
amphotericin B. Sampling of air from the patient’s
environment yielded one isolate of A. fumigatus
that matched the patient’s isolates, suggesting that
this patient acquired the infection from air in the
intensive care unit. Peritoneal aspergillosis has also
been reported following laparotomy in non-trans-
plant patients [4,293,294], and Aspergillus cholan-
gitis complicating portoenterostomy for a biliary
atresia has also been reported [295]. A case of
A. ﬂavus renal pelvis infection, following a pyelo-
lithotomy, has been described, with Aspergillus
around the suture material [296]. Post-operative
cases of wound infection [87,138,139,141–143,297],
peritonitis [297,298] and renal allograft infection
[299] have also been described following solid-
organ transplantation.Althoughnot always appar-
ent, it is possible that some of these patients had
occult foci from which the Aspergillus may have
disseminated [299–325].
Mediastinitis
Aspergillus mediastinitis in surgical patients has
been described in association with deep sternal
wound infection [4,123,125,326], heart transplan-
tation [326–329], aortitis [4,46] and patch infection
after repaired tetralogy of Fallot [113]. Two immu-
nocompetent patients were also affected during an
outbreak of aspergillosis related to a contaminated
air-handling system [4]. The importance of consid-
ering aspergillosis in the differential diagnosis of
slowly progressive, but destructive, wound infec-
tions and culture-negative mediastinitis after car-
diac surgery has been emphasised.
Breast surgery
Fungal infections of the soft tissue have been
reported in association with prosthetic breast
implants [330–333]. A healthy female, aged
39 years, with bilateral inﬂatable silicone breast
implants was colonised by A. niger as a possible
consequence of massive contamination during
surgery [331]. A. ﬂavus was also cultured from a
saline-ﬁlled implant removed from a healthy
young patient who developed unilateral breast
inﬂammation 4 years after surgery [332]. It has
been shown that fungi can grow and reproduce in
a saline-only environment, and that their survival
periods differ among species [334–336]. Colonisa-
tion of a tissue expander by A. niger, resulting in
mechanical obstruction of the device, has also
been described [337].
Linking the infection with the operating theatre
Many studies have associated the occurrence of
post-operative aspergillosis with the dissemin-
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ation of Aspergillus spores in the operating theatre.
In one investigation, pigeonexcreta andmoss in the
immediate vicinity of the ventilator intake port
were found to harbour large numbers ofAspergillus
spores [14]. Similarly,Aspergilluswas isolated from
all areas of the theatre suite in another study [38],
except in a room ﬁtted with laminar airﬂow. Air-
conditioner cooling coils and pigeon droppings on
the ledges outside the suite were found to harbour
large numbers of Aspergillus spores.
Environmental studies conducted during an
outbreak of A. ﬂavus sternal infection [123] re-
vealed massive fungal contamination in some
areas of the surgical ward [338]. When isolates
from patients and from the environment were
typed, the same genotype was detected, implica-
ting a single clonal source for the environmental
contamination and intra-operative acquisition of
A. ﬂavus. Diaz-Guerra et al. [339] reported the
simultaneous isolation of an A. ﬂavus isolate from
the aortic prosthesis of a heart surgery patient and
two isolates from a dual-reservoir cooler–heater
used in the operating theatre where this patient
received surgery. Genetic typing of these isolates
by random ampliﬁed polymorphic DNA analysis
revealed identical genotypes, indicating the no-
socomial origin of the strain. Similar results were
reported in another investigation [51], and during
an epidemiological investigation of cases of As-
pergillus aortitis following cardiac surgery [46],
high concentrations of A. fumigatus were found in
the ventilation system and on the ﬂoor of the
surgical suite.
Prevention
Most modern operating theatres have conven-
tional ventilation and ﬁlters that remove air-
borne particles ‡5 lm [340]. However, these
ﬁlters are not sufﬁcient to remove Aspergillus
spores (2.5–3.0 lm in size). Laminar airﬂow
systems and HEPA ﬁltration will remove air-
borne particles ‡0.3 lm with 99.97% efﬁciency.
These systems are generally used in orthopaedic
and other implant surgery [341], as well as in
protective environments for high-risk patients
[342–347]. Theoretically, these systems are more
effective in preventing post-operative aspergil-
losis, but data demonstrating a survival beneﬁt
for patients are lacking [348,349]. Furthermore,
these systems are limited by the expense of
construction and maintenance, and by a lack
of consensus concerning the level of airborne
conidia at which the risk can be numerically
deﬁned for aspergillosis [340].
Since outbreaks of post-operative aspergillosis
have occurred occasionally in units with HEPA
ﬁlters [78], periodic maintenance of ventilation
systems seems to be warranted [38,346,350]. Some
of these incidents were caused by contamination
of insulation in variable airﬂow volume units that
had deteriorated after becoming wet. As fungi can
inhabit water distribution systems and may cause
nosocomial infection, tap water should not be
used on surgical wounds. However, larger con-
trolled studies are needed to determine the role of
water in the transmission of aspergillosis [2,3].
The patients may also be their own source of
infection in some circumstances [159], as has been
demonstrated for staphylococcal infections. Pre-
vention of post-operative aspergillosis requires
proper disinfection techniques, as well as appro-
priate storage of surgical materials. A single
proven post-operative case of aspergillosis should
be sufﬁcient to initiate epidemiological investiga-
tions.
CONCLUSIONS
Post-operative aspergillosis seems to be an under-
appreciated problem, particularly when com-
pared with other extra-pulmonary manifestations
of invasive aspergillosis. Mortality is high for
non-cutaneous infections. Several organs and
surgical procedures may be involved, depending
on the surgery performed. These infections are
usually indolent, in some cases occurring several
months after surgery. In most patients, the source
of the spores seems to have originated from the
air during surgery, but contamination from para-
nasal sinuses, bronchopulmonary lesions, haema-
togenous dissemination and contaminated grafts
is also possible. In order to improve the outcome,
better diagnostic methods are needed. Infected
patients should receive aggressive combined
medical and surgical therapy. Prevention of these
infections should include special care of the
ventilation system in the operating theatre and
adequate sterilisation techniques.
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SUPPLEMENTARY MATERIAL
The following supplementary material is avail-
able for this article online at http://www.
blackwell-synergy.com:
Table S1. Case reports of post-operative endo-
carditis ⁄ aortitis caused by Aspergillus spp.
Table S2. Case reports of wound infections with
Aspergillus spp. following surgical procedures.
Table S3. Case reports of central nervous system
infections with Aspergillus spp. following neuro-
surgical procedures.
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